The identification of TAAs over the last decade has led to great interest in developing cancer immunotherapies that result in strong cytotoxic T-lymphocyte (CTL) responses directed to them. The most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback